Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dendreon
Dendreon
Dendreon: Q1 Earnings Preview
Seeking Alpha
Mon, 04/25/11 - 05:35 pm
earnings
Dendreon
Dendreon's Price Run May Be in Anticipation of Stronger Earnings
Seeking Alpha
Wed, 04/20/11 - 09:54 am
Dendreon
Provenge
prostate cancer
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Seeking Alpha
Mon, 04/11/11 - 02:29 pm
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Dendreon
Forest Labs
Orexigen
Why Provenge Could Be a $10 Billion Drug for Dendreon
Seeking Alpha
Mon, 04/11/11 - 11:44 am
Provenge
prostate cancer
Dendreon
vaccines
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha
Sat, 04/9/11 - 11:02 am
Prolor
Lexicon Pharmaceuticals
Dendreon
Human Genome Sciences
Targacept
Sequenom
Cadence Pharmaceuticals
Savient
ONYX Pharmaceuticals
Amylin
Emergent BioSolutions
XenoPort
Spectrum Pharmaceuticals
Incyte
Amgen
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Gilead Sciences
Exelixis
Amgen
Dendreon
Immunogen
Maxygen
MannKind
PDL Biopharma
Celgene
Geron
Vertex Pharmaceuticals
Arena Pharmaceuticals
Human Genome Sciences
Orexigen
Biogen Idec
Dendreon Faces Internet-Fueled Shareholder Uprising
Motley Fool
Sun, 04/3/11 - 09:28 am
shareholders
Dendreon
Dendreon Remains Neutral
Yahoo/Zacks
Sat, 04/2/11 - 10:13 am
Dendreon
Biotech Fever Spreads
Forbes
Thu, 03/31/11 - 12:30 pm
biotech
Cephalon
Dendreon
Celgene
Human Genome Sciences
Medicare to pay for $93,000 prostate cancer drug Provenge
Yahoo/AP
Thu, 03/31/11 - 09:58 am
Medicare
prostate cancer
Dendreon
Provenge
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Wed, 03/30/11 - 11:24 am
Yervoy
Provenge
Dendreon
Bristol-Myers Squibb
melanoma
prostate cancer
CMS Draft Guidance on Dendreon's Provenge Could Be Imminent
Seeking Alpha
Wed, 03/30/11 - 09:41 am
Dendreon
Provenge
prostate cancer
vaccines
CMS
Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
Seeking Alpha
Wed, 03/23/11 - 10:33 am
Amarin
BioDelivery Sciences
Dendreon
Human Genome Sciences
MannKind
Titan
Vanda
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Dendreon's Golden Age Is Still in Its Infancy
Seeking Alpha
Mon, 03/14/11 - 10:20 am
Dendreon
Copying Dendreon
Minyanville
Sat, 03/12/11 - 01:16 pm
Dendreon
Dendreon wins FDA nod on production increase
Fierce Pharma
Fri, 03/11/11 - 09:41 am
FDA
Dendreon
Provenge
vaccines
prostate cancer
When Will Dendreon Make Money?
Motley Fool
Thu, 03/3/11 - 07:57 am
Dendreon
vaccines
prostate cancer
Provenge
Biotech Calendar: Key Dates for March
TheStreet.com
Wed, 03/2/11 - 11:59 am
Human Genome Sciences
Dendreon
Cell Therapeutics
AP Pharma
Bristol-Myers Squibb
Celgene
Corcept Therapeutics
Achillion
Key Questions For Dendreon
Forbes
Wed, 03/2/11 - 10:32 am
Dendreon
Provenge
vaccines
prostate cancer
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »